These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

77 related items for PubMed ID: 23030592

  • 1. Loss of ARID1A expression is uncommon in gastric, colorectal, and prostate cancers.
    Kim MS, Je EM, Yoo NJ, Lee SH.
    APMIS; 2012 Dec; 120(12):1020-2. PubMed ID: 23030592
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Expressional analysis of NOLA1, NOLA2, NOLA3 and DKC1, the core proteins in H/ACA riboproteins, in gastric and colorectal cancers.
    Kim MS, Kim SS, Yoo NJ, Lee SH.
    Pathology; 2012 Oct; 44(6):576-7. PubMed ID: 22935986
    [No Abstract] [Full Text] [Related]

  • 5. Loss of ARID1A, ARID1B, and ARID2 Expression During Progression of Gastric Cancer.
    Aso T, Uozaki H, Morita S, Kumagai A, Watanabe M.
    Anticancer Res; 2015 Dec; 35(12):6819-27. PubMed ID: 26637902
    [Abstract] [Full Text] [Related]

  • 6. Aberrant expression of SWI/SNF catalytic subunits BRG1/BRM is associated with tumor development and increased invasiveness in prostate cancers.
    Sun A, Tawfik O, Gayed B, Thrasher JB, Hoestje S, Li C, Li B.
    Prostate; 2007 Feb 01; 67(2):203-13. PubMed ID: 17075831
    [Abstract] [Full Text] [Related]

  • 7. Reduced expression and loss of heterozygosity of the SDHD gene in colorectal and gastric cancer.
    Habano W, Sugai T, Nakamura S, Uesugi N, Higuchi T, Terashima M, Horiuchi S.
    Oncol Rep; 2003 Feb 01; 10(5):1375-80. PubMed ID: 12883710
    [Abstract] [Full Text] [Related]

  • 8. Expression of multidrug resistance gene (mdr-1) mRNA in gastric and colorectal cancers.
    Motoo Y, Su SB, Nakatani MT, Sawabu N.
    Anticancer Res; 1998 Feb 01; 18(3B):1903-6. PubMed ID: 9677442
    [Abstract] [Full Text] [Related]

  • 9. p300 gene alterations in colorectal and gastric carcinomas.
    Muraoka M, Konishi M, Kikuchi-Yanoshita R, Tanaka K, Shitara N, Chong JM, Iwama T, Miyaki M.
    Oncogene; 1996 Apr 04; 12(7):1565-9. PubMed ID: 8622873
    [Abstract] [Full Text] [Related]

  • 10. Inactivating frameshift mutation of PBRM1, a putative tumour suppressor gene, in colorectal cancers.
    Jo YS, Kim MS, Yoo NJ, Lee SH.
    Scand J Gastroenterol; 2016 Apr 04; 51(5):639-40. PubMed ID: 26634388
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The atypical GATA protein TRPS1 represses androgen-induced prostate-specific antigen expression in LNCaP prostate cancer cells.
    van den Bemd GJ, Jhamai M, Brinkmann AO, Chang GT.
    Biochem Biophys Res Commun; 2003 Dec 19; 312(3):578-84. PubMed ID: 14680804
    [Abstract] [Full Text] [Related]

  • 14. Loss of BAF250a (ARID1A) is frequent in high-grade endometrial carcinomas.
    Wiegand KC, Lee AF, Al-Agha OM, Chow C, Kalloger SE, Scott DW, Steidl C, Wiseman SM, Gascoyne RD, Gilks B, Huntsman DG.
    J Pathol; 2011 Jul 19; 224(3):328-33. PubMed ID: 21590771
    [Abstract] [Full Text] [Related]

  • 15. Biallelic inactivation of the RIZ1 gene in human gastric cancer.
    Tokumaru Y, Nomoto S, Jerónimo C, Henrique R, Harden S, Trink B, Sidransky D.
    Oncogene; 2003 Oct 09; 22(44):6954-8. PubMed ID: 14534544
    [Abstract] [Full Text] [Related]

  • 16. Epigenetic inactivation of class II transactivator (CIITA) is associated with the absence of interferon-gamma-induced HLA-DR expression in colorectal and gastric cancer cells.
    Satoh A, Toyota M, Ikeda H, Morimoto Y, Akino K, Mita H, Suzuki H, Sasaki Y, Kanaseki T, Takamura Y, Soejima H, Urano T, Yanagihara K, Endo T, Hinoda Y, Fujita M, Hosokawa M, Sato N, Tokino T, Imai K.
    Oncogene; 2004 Nov 25; 23(55):8876-86. PubMed ID: 15467734
    [Abstract] [Full Text] [Related]

  • 17. Frequent frameshift mutations of RIZ in sporadic gastrointestinal and endometrial carcinomas with microsatellite instability.
    Piao Z, Fang W, Malkhosyan S, Kim H, Horii A, Perucho M, Huang S.
    Cancer Res; 2000 Sep 01; 60(17):4701-4. PubMed ID: 10987271
    [Abstract] [Full Text] [Related]

  • 18. Expression of RIZ1 protein (Retinoblastoma-interacting zinc-finger protein 1) in prostate cancer epithelial cells changes with cancer grade progression and is modulated in vitro by DHT and E2.
    Rossi V, Staibano S, Abbondanza C, Pasquali D, De Rosa C, Mascolo M, Bellastella G, Visconti D, De Bellis A, Moncharmont B, De Rosa G, Puca GA, Bellastella A, Sinisi AA.
    J Cell Physiol; 2009 Dec 01; 221(3):771-7. PubMed ID: 19746436
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of cyclin D1 mRNA expression in gastric and colorectal cancers.
    Oda K, Okabayashi T, Kataoka M, Takeda A, Shibuya Y, Orita K, Tanaka N.
    Res Commun Mol Pathol Pharmacol; 1999 Dec 01; 105(3):237-52. PubMed ID: 10954128
    [Abstract] [Full Text] [Related]

  • 20. Olfactomedin-4 is a candidate biomarker of solid gastric, colorectal, pancreatic, head and neck, and prostate cancers.
    Guette C, Valo I, Vétillard A, Coqueret O.
    Proteomics Clin Appl; 2015 Feb 01; 9(1-2):58-63. PubMed ID: 25400027
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.